Labiotech – Brain Awareness Week: could ongoing R&D spur neuroscience breakthroughs?

As part of Brain Awareness Week, FundaMental Pharma’s CEO Dirk Beher discussed the potential of clinically validated pathways to address treatment-resistant depression.